These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21775762)

  • 1. Type 1 diabetes and interferon therapy: a nationwide survey in Japan.
    Nakamura K; Kawasaki E; Imagawa A; Awata T; Ikegami H; Uchigata Y; Kobayashi T; Shimada A; Nakanishi K; Makino H; Maruyama T; Hanafusa T;
    Diabetes Care; 2011 Sep; 34(9):2084-9. PubMed ID: 21775762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of patients with type 1 diabetes associated with interferon therapy.
    Nakanishi K; Saitoh S
    Diabetes Care; 2011 Feb; 34(2):471-3. PubMed ID: 21270202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon therapy in hepatitis C leading to chronic type 1 diabetes.
    Zornitzki T; Malnick S; Lysyy L; Knobler H
    World J Gastroenterol; 2015 Jan; 21(1):233-9. PubMed ID: 25574096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M; Peters T; Rasenack J; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.
    Fabris P; Floreani A; Tositti G; Vergani D; De Lalla F; Betterle C
    Aliment Pharmacol Ther; 2003 Sep; 18(6):549-58. PubMed ID: 12969081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Popescu C; Popescu GA; Arama V
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus.
    Imagawa A; Hanafusa T; Uchigata Y; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Makino H
    Diabetologia; 2005 Feb; 48(2):294-300. PubMed ID: 15688210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
    Kawazoe T; Araki M; Lin Y; Ogawa M; Okamoto T; Yamamura T; Wakakura M; Murata M
    Intern Med; 2012; 51(18):2625-9. PubMed ID: 22989839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C.
    Wasmuth HE; Stolte C; Geier A; Dietrich CG; Gartung C; Lorenzen J; Matern S; Lammert F
    BMC Infect Dis; 2004 Feb; 4():4. PubMed ID: 15040810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Cozzolongo R; Betterle C; Fabris P; Paola Albergoni M; Lanzilotta E; Manghisi OG
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):689-92. PubMed ID: 16702861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cough associated with interferon/ribavirin therapy for hepatitis C.
    Dicpinigaitis PV; Weiner FR
    J Clin Pharm Ther; 2011 Jun; 36(3):416-8. PubMed ID: 21545621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Difference between autoimmune hepatitis (AIH) with and without hepatitis C virus (HCV)].
    Hokari A; Zeniya M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):658-62. PubMed ID: 15359880
    [No Abstract]   [Full Text] [Related]  

  • 19. Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.
    Farag RE; Arafa MM; El-Etreby S; Saudy NS; Eldeek BS; El-Alfy HA; Goda IF; Ali RM
    Arch Iran Med; 2013 Feb; 16(2):68-73. PubMed ID: 23360626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.